237 related articles for article (PubMed ID: 20735753)
21. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA
Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144
[TBL] [Abstract][Full Text] [Related]
22. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain.
Qerama E; Fuglsang-Frederiksen A; Kasch H; Bach FW; Jensen TS
Neurology; 2006 Jul; 67(2):241-5. PubMed ID: 16864815
[TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain.
Adelowo A; Hacker MR; Shapiro A; Modest AM; Elkadry E
Female Pelvic Med Reconstr Surg; 2013; 19(5):288-92. PubMed ID: 23982578
[TBL] [Abstract][Full Text] [Related]
24. Myofascial pain.
Malcmacher L
Dent Today; 2013 Dec; 32(12):16. PubMed ID: 24494450
[No Abstract] [Full Text] [Related]
25. Single CT-guided chemodenervation of the anterior scalene muscle with botulinum toxin for neurogenic thoracic outlet syndrome.
Christo PJ; Christo DK; Carinci AJ; Freischlag JA
Pain Med; 2010 Apr; 11(4):504-11. PubMed ID: 20202146
[TBL] [Abstract][Full Text] [Related]
26. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome.
Correll GE; Maleki J; Gracely EJ; Muir JJ; Harbut RE
Pain Med; 2004 Sep; 5(3):263-75. PubMed ID: 15367304
[TBL] [Abstract][Full Text] [Related]
27. Consensus statement: botulinum toxin in myofascial [corrected] pain.
Reilich P; Fheodoroff K; Kern U; Mense S; Seddigh S; Wissel J; Pongratz D
J Neurol; 2004 Feb; 251 Suppl 1():I36-8. PubMed ID: 14991342
[No Abstract] [Full Text] [Related]
28. Botox combined with myofascial release physical therapy as a treatment for myofascial pelvic pain.
Halder GE; Scott L; Wyman A; Mora N; Miladinovic B; Bassaly R; Hoyte L
Investig Clin Urol; 2017 Mar; 58(2):134-139. PubMed ID: 28261683
[TBL] [Abstract][Full Text] [Related]
29. Comparison between newer local anesthetics for myofascial pain syndrome management.
Zaralidou AT; Amaniti EN; Maidatsi PG; Gorgias NK; Vasilakos DF
Methods Find Exp Clin Pharmacol; 2007 Jun; 29(5):353-7. PubMed ID: 17805438
[TBL] [Abstract][Full Text] [Related]
30. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
Baş B; Ozan B; Muğlali M; Celebi N
Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718
[TBL] [Abstract][Full Text] [Related]
31. History and uses of BOTOX (botulinum toxin type A).
Lang A
Lippincotts Case Manag; 2004; 9(2):109-12. PubMed ID: 15192508
[No Abstract] [Full Text] [Related]
32. [Botulinum toxin type A for the treatment of primary hyperhidrosis: a prospective study of 52 patients].
Martí N; Ramón D; Gámez L; Reig I; García-Pérez MA; Alonso V; Jordá E
Actas Dermosifiliogr; 2010 Sep; 101(7):614-21. PubMed ID: 20858387
[TBL] [Abstract][Full Text] [Related]
33. Role of biphosphonates and lymphatic drainage type Leduc in the complex regional pain syndrome (shoulder-hand syndrome).
Santamato A; Ranieri M; Panza F; Solfrizzi V; Frisardi V; Stolfa I; Megna M; Fiore P
Pain Med; 2009 Jan; 10(1):179-85. PubMed ID: 19222778
[TBL] [Abstract][Full Text] [Related]
34. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
[TBL] [Abstract][Full Text] [Related]
35. Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain.
Ngeow WC; Nair R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e47-50. PubMed ID: 20219585
[TBL] [Abstract][Full Text] [Related]
36. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
Braker C; Yariv S; Adler R; Badarny S; Eisenberg E
Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629
[TBL] [Abstract][Full Text] [Related]
37. A focused review on the use of botulinum toxins for neuropathic pain.
Argoff CE
Clin J Pain; 2002; 18(6 Suppl):S177-81. PubMed ID: 12569966
[TBL] [Abstract][Full Text] [Related]
38. [Long-term treatment of phantom- and stump pain with Botulinum toxin type A over 12 months. A first clinical observation].
Kern U; Martin C; Scheicher S; Müller H
Nervenarzt; 2004 Apr; 75(4):336-40. PubMed ID: 15176410
[TBL] [Abstract][Full Text] [Related]
39. Long-term functional outcome measures in corticosteroid-treated complex regional pain syndrome.
Bianchi C; Rossi S; Turi S; Brambilla A; Felisari G; Mascheri D
Eura Medicophys; 2006 Jun; 42(2):103-11. PubMed ID: 16767061
[TBL] [Abstract][Full Text] [Related]
40. Severity and specificity of neglect-like symptoms in patients with complex regional pain syndrome (CRPS) compared to chronic limb pain of other origins.
Frettlöh J; Hüppe M; Maier C
Pain; 2006 Sep; 124(1-2):184-9. PubMed ID: 16730904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
